Terumo has completed its previously announced purchase of OrganOx for nearly $1.5bn after meeting all necessary regulatory ...

EndoQuest Robotics is collaborating with NVIDIA to integrate protocols within its endoluminal robotic surgery technology as ...

Edwards Lifesciences has raised its fiscal year (FY25) guidance to between $2.56 to $2.62 per share after achieving better ...

Elucid has launched PlaqueIQ, an AI-based image analysis software that quantifies plaque build-up to evaluate a patient’s ...

Roche has obtained CE mark approval for its fully automated immunoassay, Elecsys Dengue Ag test, intended for diagnosing ...

South Korea-based MOPIC has introduced an autostereoscopic 3D display aimed at endoscopic and microscope imaging applications ...

VentureMed has raised $28m to accelerate the commercial adoption and expand indications for its FLEX Vessel Preparation (FLEX ...

GE HealthCare has raised its fiscal year 2025 (FY25) profit outlook to between $3.02 and $3.04 per share amid solid demand ...

Co-Dx has signed a definitive agreement with Arabian Eagle Manufacturing to create a joint venture (JV) for PCR platform ...

The FDA has granted breakthrough device designation to Augurex’s SPINEstat 14-3-3eta Autoantibody Multiplex Immunoassay Test.

AtriCure has treated the first subject in the randomised Box Lesion Creation with Left Atrial Appendage Exclusion to Reduce ...

Pearsanta, a subsidiary of Aditxt, has commenced enrolment in a clinical trial to assess the blood-based Mitomic ...